The ranges do not identify a capsule, tablet, liquid or release profile. The listing does not establish a clinical indication or a benefit for a lower-strength preparation.
Review the complete preparation and its evidence.
Reference naltrexone hydrochloride tablet labeling includes opioid-related contraindications, precipitated withdrawal and liver-injury warnings. That label does not identify these source entries or validate their unspecified dosage forms, strength ranges or indications. DailyMed: naltrexone hydrochloride tablet reference labeling
Compounded drugs are not FDA-approved and do not undergo FDA premarket review for safety, effectiveness or quality. For a commercially manufactured product, verify its exact identity and current labeling separately. FDA: compounded drug information
Sources checked October 20, 2026. This page provides product information, not diagnosis, treatment selection, dosing or administration instructions.